Amir Gross

Rainbow Medical Ltd. (Rainbow Medical) is a venture capital firm founded in 2007 by Efi Cohen Arazi and Yossi Gross. The firm is headquartered in HaMerkaz, Israel with an additional offices in China and United States.

Israel Aerospace Industries Ltd. engages in the development, sale, and maintenance of commercial and military aircrafts, missiles, and military electronic products. It operates through the following segments: Aviation, Military Aircraft, Missiles and Space Systems, and Elta Systems Ltd. The Aviation segment engages in the maintenance, renovation, and improvement of aircraft and aircraft engines, and conversion of passenger aircraft into cargo and refueling aircraft, and in the development and manufacture of aviation assemblies for military and commercial aircraft. The Military Aircraft segment engages in the development, manufacture, and sale of unmanned aircraft. The Missiles and Space Systems segment engages in the development, manufacture, and sale of attack and defense missile systems, satellites, and space assemblies. The Elta Systems Ltd segment engages in the military electronics field. The company was founded in 1953 and is headquartered in Lod, Israel.

CardioNet LLC provides cardiac monitoring services. It operates its business through two segments: Patient Service and Product Business. The Patient Service segment focuses on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, through its core mobile cardiac outpatient telemetry, event and Holter services. The Product Business segment focuses on the development, manufacturing, testing and marketing of medical devices and related software to medical companies, clinics and hospitals. The company was founded by James M. Sweeney in 1999 and is headquartered in Conshohocken, PA.

NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York.

Small Bone Innovations, Inc. develops and markets implants for the small bones and joints. It offers Star Ankle, A3 fusion nail, Auto fix stainless steel, Stafix, mini rail system, Fusifix, Silicon pip, Stability sigmoid notch, Rhead, Uni-Elbow radio capitellum and Autofix. The company was founded by Anthony G. Viscogliosi, John L. Viscogliosi, and Marc R. Viscogliosi in May 2004 and is headquartered in Morrisville, PA.

Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO.

4Tech Cardio Ireland Ltd. develops and manufactures surgical devices. The company was founded in 2011 and is headquartered in Waltham, MA.

Vascular Dynamics, Inc. provides blood pressure modulation devices. It develops and commercializes a passive, catheter-delivered implant for the treatment of hypertension. The company was founded in 2008 and is headquartered in Mountain View, CA.

Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN.

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities.

Vesalius Ventures, Inc (Vesalius Ventures) is a venture capital firm founded in 2002. The firm is headquartered in Houston, Texas.

Stryker GI Ltd. develops, manufactures and markets advanced endoscopic solutions for gastroenterological applications. The company was formerly known as SightLine Technologies. Stryker GI Israel was founded by Giora Bernat in December 1994 and is located in Haifa, Israel.

EarlySense Ltd. provides patient monitoring systems. It offers continuous patient monitoring for heart rate, respiratory rate and motion, to potentially allow the clinical team to manage early detection of patient deterioration, fall prevention and pressure ulcers prevention. The firm develops system specifically for medical surgical, general care patients who are usually monitored by nurses once every four to six hours. The company was founded by Avner Halperin, Daniel H. Lange, Guy Shinar and Yossi Gross in 2004 and is headquartered in Ramat Gan, Israel.

G.I. View Ltd. develops endoscopy products for gastrointestinal applications. It offers edge endoscopes for the gastrointestinal market that set its products. The company was founded by Benad Goldwasser, Oz Cabiri and Yossi Gross in 2003 and is headquartered in Ramat Gan, Israel.

BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel.

DuoCure Ltd. develops intraluminal minimally invasive implantable devices for the treatment of obesity. The company was founded by Elad Magal, Yossi Gross and Yael Karasik in 2005 and is headquartered in Tel Aviv, Israel.

BetaStim Ltd. develops medical devices. The firm's implantable pulse generator is used to treat type II diabetes by applying electrical stimulation and monitoring gastrointestinal electrical activity. The company was founded by Yossi Gross and Jacob Ben Arie in 2006 and is headquartered in Caesarea, Israel.

Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.

Maxillent Ltd. develops and manufactures dental implants. Its products include iraise, isure, prosthetics, surgical instruments and bone graft materials. The company was founded in 2008 and is headquartered in Herzliya, Israel.

Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel.

GluSense Ltd. develops technology for Continuous Glucose Monitoring. The firm develops a miniature, Long-Term, Implantable Continuous Glucose Monitoring (CGM) system for diabetes patients, this system includes a miniature sensor implanted under the skin and an external wearable unit, e.g. a watch. Its wearable unit reads the signal from the implant and provides basic display and alarms. The company was founded by Yossi Gross in 2007 and is headquartered in Rehovot, Israel.

Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA.

Nano Retina Ltd. develops artificial retina designed to restore sight. It also develops an implantable bionic chip, designed to return sight to those blinded by retinal degenerative diseases. The company was founded by Yossi Gross and James R. Von Her, II in 2009 and is headquartered in Herzliya, Israel.

Momentis Surgical Ltd. provides robot-assisted surgeries. It offers Hominis, a surgical system with surgical and ergonomics capabilities. The company was founded by Vitaly Vishnepolsky and Nir Shvalb and is headquartered in Or Yehuda, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Cordio Medical Ltd. engages in the provision of solutions for monitoring health conditions through speech analysis. The company was founded by Sigal Kremer Tal, Ze'ev Schlik, Shelly Lotan, and Aviv Lotan in 2013 and is headquartered in Or Yehuda, Israel.

ChroniSense Medical Ltd. provides healthcare services. It develops wearable medical-grade devices that monitor vital signs and other health factors. The firm''s sensors measure medical data from blood oxygen and ECG to blood pressure, cardiac output and vascular resistance, and communicate that data to caregivers in real time. The company was founded by Danny B. Lange and Yossi Gross in 2015 and is headquartered in Yokneam, Israel.

Part of Venus Medtech (Hangzhou), Inc., Cardiovalve Ltd. is an Israeli medical device company that specializes in developing the Cardiovalve transcatheter system. The company is based in Or Yehuda, Israel. The system is designed to replace regurgitating mitral and tricuspid valves using a transfemoral-transseptal approach. The CEO of the company is Amir Gross. Cardiovalve was acquired by Athena Medtech Holding Ltd. on January 25, 2022 for $83.98 million.

Discure Technologies manufactures medical equipment. The company is based in Herzliya, Israel. The Israeli company was founded by Yossi Gross. The CEO is Yuval Mandelbaum.